Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Vibrating wearables put stroke walking to the test

NCT ID NCT07831642

NEW Symptom relief Sponsor: Geisinger Clinic Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 · Last updated Sep 21, 2026

Summary

Stroke survivors often walk more slowly and struggle to produce the movements needed for efficient walking. This study tests whether small wearable devices that vibrate during walking can help people with chronic stroke change specific walking movements linked to speed, propulsion, and balance. Participants complete one visit with walking trials and balance tests, with and without the vibration feedback, while motion capture and sensors measure their movement. Researchers aim to understand how this feedback might support future rehabilitation approaches.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a wearable vibrotactile feedback system that vibrates to signal when walking goals are met
What this could lead to
If it works, this could point toward wearable feedback tools that help stroke survivors retrain their walking in rehabilitation.
What could go wrong
This is a small, single-visit study, so any changes seen in one session may not last or translate into everyday walking. The device may not help everyone, and results could differ outside a lab.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 32 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 to 85 years * Willing and able to provide informed consent * Single unilateral stroke at least 6 months prior to enrollment * ICD diagnosis code for hemiparesis (I69.35X) * Independently ambulatory (cane acceptable; orthosis may require further evaluation) * Resting heart rate 40 to 100 beats per minute * Resting blood pressure 90/60 to 170/90 mmHg * Active hip extension of at least 5 degrees * Active ankle dorsiflexion to neutral with the knee extended Exclusion Criteria: * Evidence of cerebellar stroke * Other neurological conditions * Lower-limb botulinum toxin injections within the previous 4 months * Pain that limits walking * Unable to communicate with investigators * Signs of unilateral neglect * Unexplained dizziness within the previous 6 months * Fall within the previous 6 months * Congestive heart failure * Chronic obstructive pulmonary disease * Severe peripheral vascular disease * Score greater than 1 on question 1b of the NIH Stroke Scale * Score greater than 0 on question 1c of the NIH Stroke Scale * Currently pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemiparesis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hemiplegia Paresis stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemiparesis Stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.